ARONORA
Aronora is a translational biotechnology company (aronorabio.com) engaged in the early-stage commercial development of proprietary biologic therapeutics, including recombinant monolconal antibodies and enzymes.
ARONORA
Industry:
Biotechnology
Founded:
2007-01-01
Address:
Portland, Oregon, United States
Country:
United States
Website Url:
http://www.aronorabio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content Organization Schema Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Neumedicines
Neumedicines is a biotechnology company that focuses on the development of protein therapeutics.
Current Employees Featured
Founder
Investors List
NYBC Ventures
NYBC Ventures investment in Seed Round - Aronora
Official Site Inspections
http://www.aronorabio.com
- Host name: premium10-3.web-hosting.com
- IP address: 198.187.31.101
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Aronora"
Aronora - Crunchbase Company Profile & Funding
Aronora is a translational biotechnology company (aronorabio.com) engaged in the early-stage commercial development of proprietary biologic therapeutics, including recombinant monolconal antibodies and enzymes.See details»
Aronora, Inc.: Contact Details and Business Profile - RocketReach
Aronora is a translational biotechnology company (aronorabio.com) engaged in the development of proprietary biologic therapeutics, including recombinant monolconal antibodies and โฆSee details»
Aronora, Inc. Overview | SignalHire Company Profile
The position of the President & CEO is occupied by Andras Gruber. Its headquarters is located at Portland, Oregon, USA. The number of employees ranges from 1 to 25. The Aronora, Inc. โฆSee details»
Aronora Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Aronora. Use the PitchBook Platform to explore the full profile.See details»
Aronora, Inc. - LinkedIn
Aronora is a translational biotechnology company (aronorabio.com) engaged in the development of proprietary biologic therapeutics, including recombinant monolconal antibodies and โฆSee details»
ARONORA, LLC | VentureRadar
Aronora is a privately held, early clinical stage translational biopharmaceutical company engaged in the discovery, research, and commercial development of proprietary biological therapeutics. โฆSee details»
Aronora - Company Profile & Staff Directory | ContactOut
Aronora is a translational biotechnology company (aronorabio.com) engaged in the development of proprietary biologic therapeutics, including recombinant monolconal antibodies and โฆSee details»
Aronora, Inc. - Drug pipelines, Patents, Clinical trials - Patsnap
Explore Aronora, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 1 news, and 52 literature, Technology Platform:Monoclonal ...See details»
Aronora - Overview, News & Similar companies | ZoomInfo.com
Oct 12, 2023 View Aronora (www.aronorabio.com) location in Oregon, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
Paradigm Shifting Therapies for Serious Hematologic Diseases
Oct 12, 2023 At Aronora we are developing paradigm shifting therapies for serious hematologic diseases.See details»
Aronora Company Profile - Office Locations, Competitors, Revenue ...
Aronora has 5 employees across 2 locations. See insights on Aronora including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Aronora, Inc. | MedPath
Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis Phase 2 Completed Conditions End Stage Renal Disease Thrombosis โฆSee details»
Aronora Secures Investment From New York Blood Center - Yahoo โฆ
Oct 12, 2023 Ms. Wood will serve as a member on Aronora's Board of Directors. Contact Information Norah Verbout Director of Strategic Partnerships [email protected] (503) 530 โฆSee details»
Aronora, Inc. - Sinodo Medical
Aronora is a clinical-stage biotech company committed to developing next generation therapeutics for blood clotting diseases. Thrombi (pathological โbad clotsโ) that plug up blood vessels lead โฆSee details»
Aronora, Inc. (Aronora, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ_ โฆ
Contact Information Norah Verbout Director of Strategic Partnerships [email protected] (503) 530-6842 SOURCE: Aronora, Inc. View source version on accesswire.com:See details»
Aronora Biopharmaceuticals 2011-2012 SBIR CAP Virtual Showcase
Target Markets: Worldwide market for drugs that prevent or treat thrombotic vascular disorders is over $40 billion per year. Their limited safety is a significant obstacle to their efficient and safe โฆSee details»
Aronora Secures Investment From New York Blood Center
Oct 12, 2023 Aronora, Inc., a clinical-stage biotech poised to revolutionize blood clot treatment and prevention, today announced it has closed an investment from NYBC Ventures, a venture โฆSee details»
ARONORA, LLC - VentureRadar
Private Company "Aronora is a privately held, early clinical stage translational biopharmaceutical company engaged in the discovery, research, and commercial development of proprietary โฆSee details»
Aronora_FCOI
Under the requirements the organization will do the following: -Have an up-to-date, written and enforced administrative process to identify and manage, reduce, or eliminate conflicting โฆSee details»
Abera and Orexo partner for vaccine powder formulations
1 day ago Abera and Orexo have entered a partnership to develop and test the powder formulations of the formerโs vaccine candidates.See details»